QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
NASDAQ:EYE

National Vision - EYE Stock Forecast, Price & News

$35.62
-0.03 (-0.08%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$35.19
$36.03
50-Day Range
$25.28
$35.65
52-Week Range
$22.59
$65.92
Volume
1.08 million shs
Average Volume
1.30 million shs
Market Capitalization
$2.90 billion
P/E Ratio
36.35
Dividend Yield
N/A
Price Target
$51.29

National Vision MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
44.0% Upside
$51.29 Price Target
Short Interest
Healthy
10.23% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.35
Upright™ Environmental Score
News Sentiment
0.93mentions of National Vision in the last 14 days
Based on 24 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
62.26%
From $0.53 to $0.86 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.53 out of 5 stars

Medical Sector

175th out of 1,125 stocks

Ophthalmic Goods Industry

4th out of 7 stocks

EYE stock logo

About National Vision (NASDAQ:EYE) Stock

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 1, 2022, the company operated through 1,278 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

National Vision Stock Performance

Shares of EYE traded down $0.03 during mid-day trading on Monday, hitting $35.62. 1,075,372 shares of the company's stock were exchanged, compared to its average volume of 1,298,677. The stock's 50-day simple moving average is $29.44 and its 200-day simple moving average is $34.69. The firm has a market cap of $2.90 billion, a price-to-earnings ratio of 36.35, a price-to-earnings-growth ratio of 3.03 and a beta of 1.66. The company has a quick ratio of 0.99, a current ratio of 1.36 and a debt-to-equity ratio of 0.63. National Vision has a 52 week low of $22.59 and a 52 week high of $65.92.

National Vision (NASDAQ:EYE - Get Rating) last released its quarterly earnings data on Thursday, August 11th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.08 by $0.13. The business had revenue of $509.60 million during the quarter, compared to analysts' expectations of $500.67 million. National Vision had a net margin of 4.28% and a return on equity of 8.34%. The firm's quarterly revenue was down 7.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.42 EPS. On average, equities research analysts expect that National Vision will post 0.53 EPS for the current year.

Analysts Set New Price Targets

EYE has been the subject of several research analyst reports. The Goldman Sachs Group upgraded shares of National Vision from a "neutral" rating to a "buy" rating and upped their target price for the company from $31.00 to $32.00 in a research note on Monday, June 27th. Morgan Stanley lowered their target price on shares of National Vision from $65.00 to $40.00 and set an "overweight" rating on the stock in a report on Thursday, June 16th. One investment analyst has rated the stock with a sell rating and five have given a buy rating to the company's stock. According to MarketBeat, National Vision presently has an average rating of "Moderate Buy" and an average price target of $51.29.

Receive EYE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter.

EYE Stock News Headlines

National Vision Q2 Profit Down, Cuts FY22 View; Names New COO, CFO
Growing vision problems
ONE VOICE, ONE VISION... TO SAVE AND HEAL LIVES
See More Headlines
Receive EYE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter.

EYE Company Calendar

Last Earnings
8/11/2022
Today
8/15/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EYE
Fax
N/A
Employees
13,735
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$49.63
High Stock Price Forecast
$70.00
Low Stock Price Forecast
$32.00
Forecasted Upside/Downside
+44.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$128.24 million
Pretax Margin
5.19%

Debt

Sales & Book Value

Annual Sales
$2.08 billion
Cash Flow
$2.66 per share
Book Value
$11.20 per share

Miscellaneous

Free Float
77,073,000
Market Cap
$2.90 billion
Optionable
Optionable
Beta
1.66














EYE Stock - Frequently Asked Questions

Should I buy or sell National Vision stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for National Vision in the last twelve months. There are currently 1 sell rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" EYE shares.
View EYE analyst ratings
or view top-rated stocks.

What is National Vision's stock price forecast for 2022?

6 brokers have issued twelve-month price objectives for National Vision's shares. Their EYE share price forecasts range from $32.00 to $70.00. On average, they predict the company's stock price to reach $51.29 in the next twelve months. This suggests a possible upside of 43.1% from the stock's current price.
View analysts price targets for EYE
or view top-rated stocks among Wall Street analysts.

How have EYE shares performed in 2022?

National Vision's stock was trading at $47.99 at the beginning of 2022. Since then, EYE shares have decreased by 25.3% and is now trading at $35.83.
View the best growth stocks for 2022 here
.

When is National Vision's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our EYE earnings forecast
.

How were National Vision's earnings last quarter?

National Vision Holdings, Inc. (NASDAQ:EYE) announced its quarterly earnings results on Thursday, August, 11th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.08 by $0.13. The business earned $509.60 million during the quarter, compared to the consensus estimate of $500.67 million. National Vision had a net margin of 4.28% and a trailing twelve-month return on equity of 8.34%. The company's revenue for the quarter was down 7.3% compared to the same quarter last year. During the same period last year, the business earned $0.42 EPS.

How will National Vision's stock buyback program work?

National Vision declared that its board has authorized a stock repurchase program on Monday, November 29th 2021, which authorizes the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 2.5% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.

What guidance has National Vision issued on next quarter's earnings?

National Vision issued an update on its FY22 earnings guidance on Thursday, August, 11th. The company provided EPS guidance of $0.65-$0.77 for the period, compared to the consensus earnings per share estimate of $0.73. The company issued revenue guidance of $1.99-$2.02 billion, compared to the consensus revenue estimate of $2.05 billion.

What is L. Reade Fahs' approval rating as National Vision's CEO?

243 employees have rated National Vision Chief Executive Officer L. Reade Fahs on Glassdoor.com. L. Reade Fahs has an approval rating of 97% among the company's employees. This puts L. Reade Fahs in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of National Vision own?
When did National Vision IPO?

(EYE) raised $300 million in an IPO on Thursday, October 26th 2017. The company issued 15,800,000 shares at a price of $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sachs, Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank and Wells Fargo Securities served as the underwriters for the IPO and Guggenheim Securities, Mizuho Securities and Macquarie Capital were co-managers.

What is National Vision's stock symbol?

National Vision trades on the NASDAQ under the ticker symbol "EYE."

Who are National Vision's major shareholders?

National Vision's stock is owned by a number of retail and institutional investors. Top institutional shareholders include William Blair Investment Management LLC (9.54%), Clearbridge Investments LLC (5.15%), TimesSquare Capital Management LLC (2.16%), Riverbridge Partners LLC (1.43%), abrdn plc (1.31%) and Northern Trust Corp (1.11%). Insiders that own company stock include Jared Brandman, L Reade Fahs, Melissa Rasmussen, Mfn Partners, Lp, Patrick R Moore, Thomas V Taylor and Virginia A Hepner.
View institutional ownership trends
.

How do I buy shares of National Vision?

Shares of EYE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Vision's stock price today?

One share of EYE stock can currently be purchased for approximately $35.83.

How much money does National Vision make?

National Vision (NASDAQ:EYE) has a market capitalization of $2.92 billion and generates $2.08 billion in revenue each year. The company earns $128.24 million in net income (profit) each year or $0.98 on an earnings per share basis.

How many employees does National Vision have?

The company employs 13,735 workers across the globe.

How can I contact National Vision?

National Vision's mailing address is 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096. The official website for the company is www.nationalvision.com. The company can be reached via phone at (770) 822-3600 or via email at investor.relations@nationalvision.com.

This page (NASDAQ:EYE) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.